Cerca in questo sito

Excessive drug use in children can cause developmental delay. tVNS provides long-term positive results by reducing the need for drug use. tVNS is safe for children and approved for pediatric use. tVNS provides benefits in mental development and motor development. Use of tVNS® in Children tVNS is safe for children and MDR CE approved for pediatric use Epilepsy, Autism, Prader Willy Syndrom are the approved indications Young children should use the device under parental supervision. Excessive drug use in children can cause developmental delay. tVNS provides long-term positive results by reducing the need for drug use. Reducing drug use helps prevent the side effects of anti-epileptic drugs Improves energy, concentration, and mood Children who are using the therapy in the long term can experience cognitive and motor improvement

Drug-free non-surgical tvns vagal nerve stimulation in the treatment of tinnitus. The most up-to-date health information on tinnitus causes, symptoms, treatment options Tinnitus Tinnitus and Vagus Nerve Stimulation Tinnitus can also be defined as the patient's perception of a sound without an acoustic stimulus. This sound can have different tones, features and characters. The sound most often heard as ringing is sometimes described as humming, bells, wind or whistling, machinery noise, rustling, pulsing sounds. Tinnitus is considered as a symptom rather than a disease and is treated as such. It is the most common symptom of the auditory system. These complaints may be severe enough to cause mental problems or severely impair the quality of life, and in some people, tinnitus may come and go within a few minutes. Clinical studies have shown that vagus nerve stimulation provides an increase in parasympathetic activity, calms the patient, reduces sleep disorders due to tinnitus, and decreases THI (Tinnitus Handicap Inventoy). For more detailed information, please contact tVNS Turkey. Contact us

tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices. About Us tVNS Health Gmbh is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy. The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients' quality of life. Meet the Founders Berkay Gezen is an enthusiastic professional with 28+ global business development and medical brand management. He has served as the global commercial director of CardiAid, brand for 11 years, from the design of the brand to its expansion in over 65 countries of the world. Following his creative vision of AED and his experience in global development, he became the founder of tVNS Health to focus on neuromodulation and vagus nerve stimulation technologies, sales, services and distribution for tVNS. With his expertise in market building, he become the implementer of projects that make a difference in more than 80 countries of the world. He has dedicated his professional life to increasing the awareness of public access defibrillators and neuromodulation. With his motivation, he inspires the medical community and continues to manage medical channel in more than 50 countries worldwide. Kurtuluş Berkay Gezen Selin Erdogan Gezen She is a visionary leader in the field of neuromodulation technologies and global business development. After pivotal roles in renowned companies like Vodafone, Garanti BBVA Bank, and Hewlett Packard, as program management in innovative technology projects, Selin embarked on a new chapter as a founding partner of Nervovita Medical Technologies and tVNS Health, focusing on neuromodulation therapies. Her dedication led to the accessibility of transcutaneous vagal nerve stimulation, revolutionizing treatment options around the globe. She collaborates with leading universities and institutes in over 40 countries, driving clinical studies across various diseases. She is designing the human-machine interaction for better usability of wearable medical devices. "Our mission is to empower individuals worldwide with innovative neuromodulation and bio-electronic solutions that enhance well-being and improve lives. Committed to advancing healthcare through cutting-edge technology, we strive to be the global leader in distributing the transcutaneous vagus nerve stimulation devices. Guided by a dedication to excellence, integrity, and social responsibility, our company aims to establish a pervasive presence in the global market, ensuring accessibility to the transformative benefits of the tVNS devices. We are driven by a passion for improving mental and physical health, fostering a world where individuals can achieve their full potential and lead fulfilling lives. Our commitment extends beyond the distribution; we aim to build enduring partnerships with healthcare professionals, research institutions, and distributors to foster a collaborative ecosystem. By prioritizing customer satisfaction, continuous innovation, and ethical business practices, we aim to create a positive impact on the well-being of communities around the globe." Our Mission Our Vision "We envision a future where transformative neuromodulation technology becomes an integral part of global healthcare, revolutionizing the way individuals manage and enhance their well-being. Guided by innovation, compassion, and a commitment to excellence, we aspire to establish ourselves as the foremost global influence, ensuring universal access, recognition, and trust in the widespread expansion of transcutaneous vagus nerve stimulation technologies (taVNS). We aspire to lead the charge in advancing the field of neuromodulation, continuously pushing the boundaries of what is possible to unlock the full potential of the human body's innate healing mechanisms. By fostering a culture of curiosity, collaboration, and inclusivity, we aim to inspire a global movement toward proactive and personalized healthcare solutions. Through strategic partnerships, ongoing research, and a commitment to ethical business practices, we seek to shape a healthcare landscape where preventative and holistic approaches are celebrated. As we strive for excellence, our vision extends beyond business success to contributing significantly to the betterment of society. We see a world where the neuromodulation becomes a beacon of hope, fostering resilience, and promoting a culture of well-being that transcends borders. We are dedicated to pioneering a future where the power of neuromodulation transforms lives, creating a healthier, happier, and more connected global community." tVNS Health GmbH Headquarter Südliche Münchner Str. 62, 82031 Grünwald, Germany info@tvns.health www.tvns.health Contact tVNS Health info@tvns.health Contact Form

TVNS treatment in Crohn's disease. The most up-to-date health information on crohn's disease causes, symptoms, treatment options Crohn's Disease Groundbreaking Technologies for Life What is Crohn's Disease ? Crohn's disease is a type of inflammatory bowel disease that causes inflammation of the gastrointestinal tract from the mouth to the anus. This inflammation can be attached to one or more parts of the digestive system, but it is usually seen in the ileum, which is the last part of the small intestine, and in the beginning of the large intestine. Crohn's disease can cause inflammation in your digestive tract, leading to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. Growth-development retardation in children may be signs of Crohn's disease. Extra-intestinal diseases are also observed in a quarter of Crohn's patients. These mostly occur in the skin, joints, eyes, liver and biliary tract, kidney and urinary tract, vascular heart and lungs. Crohn's Disease Symptoms Diarrhea Abdominal pains Intestinal blockages Fever Fatigue Loss of appetite and weight loss Still feeling full after using the toilet Frequent toileting is one of the early symptoms of Crohn's disease. Insomnia Tanı Yöntemleri Crohn's Disease Causes Immune system: It is possible for a virus or bacteria to trigger Crohn's disease; however, scientists have yet to identify such a trigger. When your immune system tries to fight off the invading microorganism, an abnormal immune response can cause the immune system to attack cells in the digestive tract as well. Heredity: Crohn's disease is more common in people with a family history of the same disease, so genes may play a role in the occurrence of the disease. Crohn's Disease Diagnostic Methods Blood analysis Stool analysis Stomach, small and large intestine films Colonoscopy and endoscopy CT and MRI images Crohn's disease can occur at any age, but it usually occurs when the disease is young. Most people who develop Crohn's disease are diagnosed before they reach the age of about 30. You are at higher risk for the disease if you have a first-degree relative with the disease, such as a parent, sibling, or child. About 1 in 5 people with Crohn's disease have a family member with the disease. Facts About Crohn's Disease Treatment Options for Crohn's Disease Medication Steroid drugs: These are drugs to reduce inflammation in the digestive system. Drugs for the immune system: These are drugs used to control the immune system. More information Surgical treatment Most Crohn's Disease patients may need surgical treatment. Removing the problematic parts of the digestive system and reconnecting them to healthy parts is the aim of surgical treatment. More information Crohn's Disease Diet In general, the patient is given a high-energy, abundant protein, low-fiber, low-fat diet rich in vitamins and minerals. For some patients, consumption of milk and dairy products is prohibited. More information Transcutaneous Vagus Nerve Stimulation (tVNS) tVNS ® reduces inflammation in the intestine, allowing the intestine to do its job more healthily. More information Contact us

Contact Us This is your Contact section paragraph. Encourage your reader to reach out with any questions, comments or to take a different action specific to your site. 500 Terry Francine Street, San Francisco, CA 94158 info@mysite.com 123-456-7890 First Name Last Name Email Message Send Thanks for submitting! Facebook Twitter Instagram Linkedin Opening Hours Mon - Fri 8:00 am – 8:00 pm Saturday 9:00 am – 7:00 pm Sunday 9:00 am – 9:00 pm

Our Services This is your Services Page. It's a great opportunity to provide information about the services you provide. Double click on the text box to start editing your content and make sure to add all the relevant details you want to share with site visitors. Whether you're offering multiple services, courses or programs, you can edit this space to fit your website's needs. Simply double click on this section to open the content manager and modify the content. Explain what each item entails and add photos or videos for even more engagement. Service Name I'm a paragraph. Click here to add your own text and edit me. It’s easy. Service Name I'm a paragraph. Click here to add your own text and edit me. It’s easy. Service Name I'm a paragraph. Click here to add your own text and edit me. It’s easy. Service Name I'm a paragraph. Click here to add your own text and edit me. It’s easy. Get a Quote This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content. First Name Last Name Email Send Thanks for submitting!

Ricerca e Neuromodulazione Pionieristica con tVNS® Scoprite perché tVNS® è il dispositivo preferito per la ricerca sulla stimolazione transcutanea del nervo vago. Grazie alla precisa stimolazione della cymba concha e alla flessibilità wireless dei parametri, tVNS offre una tecnologia all’avanguardia e un’incomparabile adattabilità per esplorare nuovi protocolli terapeutici. Approvato secondo il regolamento UE sui dispositivi medici (EU-MDR) e supportato da rapporti CB, il nostro dispositivo tVNS garantisce il rispetto dei più alti standard di sicurezza ed efficacia nella ricerca medica. tVNS® R per la Ricerca Dispositivo di Stimolazione Transcutanea del Nervo Vago per la Ricerca Programmazione completa e wireless dei parametri App paziente per la raccolta dati Supporto per studi clinici Stimolazione Triggered tVNS® Elettrodi Legacy ed Hook Stimolazione Sham I dispositivi tVNS® sono affidati da istituzioni leader a livello mondiale To play, press and hold the enter key. To stop, release the enter key. Perché siamo leader nella stimolazione del nervo vago? Da oltre 20 anni, il nostro impegno nell’innovazione ci ha posizionati all’avanguardia nella stimolazione non invasiva del nervo vago. I nostri sforzi unici di ricerca e sviluppo sono supportati da solidi trial clinici, garantendo dispositivi non solo efficaci ma anche sicuri e affidabili. Come dispositivo medico di Classe IIa approvato secondo EU-MDR, offriamo soluzioni scientificamente validate in un mercato affollato da alternative non verificate. Dal lancio del dispositivo Cerbomed Nemos®, abbiamo guidato il mercato nella tecnologia non invasiva del nervo vago. Il nostro approccio pionieristico e l’innovazione continua ci mantengono al passo avanti, con dispositivi preferiti da professionisti sanitari e ricercatori per sicurezza, affidabilità e precisione impareggiabili. Sviluppati e prodotti in Germania, i nostri dispositivi rispettano i più alti standard qualitativi, riflettendo la nostra dedizione all’eccellenza e al benessere dei pazienti. Learn More About tVNS Health GmbH Perché scegliere i nostri dispositivi tVNS® per la ricerca? Il nostro dispositivo tVNS® è l’unico stimolatore non invasivo del nervo vago approvato come dispositivo medico di Classe IIa secondo il Regolamento UE sui Dispositivi Medici (EU-MDR). tVNS® si distingue per il suo approccio non invasivo e clinicamente validato, offrendo un’alternativa più sicura e confortevole rispetto ai metodi invasivi. Mirando unicamente alla cymba concha per una innervazione al 100% del ramo auricolare del nervo vago (ABVN) con il nostro elettrodo brevettato, tVNS® garantisce la massima efficacia rispetto ad altri dispositivi che raggiungono solo un’innervazione parziale. Presentazione del tVNS® Triggerbox Uscito il 1° dicembre 2024, il tVNS® Triggerbox rappresenta un avanzamento nella ricerca sulla neuromodulazione, fornendo un sistema cablato che minimizza le latenze e migliora la riproducibilità dei protocolli. Questo progresso fondamentale garantisce configurazioni sperimentali precise e affidabili per studi all’avanguardia. EU-MDR Cla ss IIa Dispositivo medico approvato Il nostro dispositivo tVNS® E è l’unico dispositivo di stimolazione non invasiva del nervo vago approvato come dispositivo medico secondo EU-MDR. I rapporti CB completi non solo evidenziano la sicurezza e l’efficacia del dispositivo, ma facilitano anche i processi di approvazione etica per i protocolli di ricerca. EU-MDR Cla ss IIa Stimolazione della cymba concha Approfittate del design dell’elettrodo che stimola la cymba concha, metodo preferito dai ricercatori per la sua innervazione al 100% del ramo auricolare del nervo vago (ABVN). Questo approccio mirato è progettato per massimizzare i risultati terapeutici, coinvolgendo il nervo vago in modo più efficace rispetto ad altri metodi non invasivi. EU-MDR Cla ss IIa Connettività wireless e programmabilità Sfruttate la potenza della tecnologia wireless per un’operatività e gestione dati senza interruzioni. L’app tVNS® Research permette la programmazione remota dei parametri di stimolazione, offrendo la flessibilità necessaria per adattarsi alle esigenze in evoluzione di protocolli di ricerca complessi, senza interrompere l’esperienza del partecipante. EU-MDR Cla ss IIa Prodotto in Germania Affidatevi alla qualità e affidabilità di un dispositivo progettato e prodotto con orgoglio in Germania. Il nostro impegno per l’eccellenza garantisce che ogni dispositivo tVNS® rispetti i più elevati standard di prestazioni, durata e sicurezza, rendendolo la scelta ideale per istituzioni che richiedono il meglio per la ricerca. EU-MDR Cla ss IIa Elettrodo in titanio-iridio Il nostro dispositivo tVNS® è dotato di elettrodi in titanio-iridio, spesso usati negli impianti e noti per la loro biocompatibilità, che offrono una stimolazione ottimale con minima irritazione. Questa scelta superiore ci distingue dalle alternative in acciaio inox, assicurando un’esperienza terapeutica più confortevole ed efficace. EU-MDR Cla ss IIa Trattamento dati conforme al GDPR Con un impegno per la privacy e la sicurezza, il sistema tVNS® assicura che tutti i dati raccolti tramite l’app vengano trattati in rigorosa conformità al Regolamento Generale sulla Protezione dei Dati (GDPR). I ricercatori possono raccogliere, archiviare e analizzare dati sensibili con la certezza che la privacy dei partecipanti è tutelata. EU-MDR Cla ss IIa Rete globale di istituzioni fidate Entrate a far parte di una stimata comunità di ricercatori provenienti da università e ospedali leader nel mondo che hanno scelto tVNS® per i loro studi, contribuendo all’avanzamento della ricerca neurologica e della cura del paziente. EU-MDR Cla ss IIa Oltre 20 anni di esperienza Con più di 20 anni di ricerca e sviluppo dedicati, abbiamo orgogliosamente sviluppato il primo stimolatore non invasivo del nervo vago approvato al mondo, il dispositivo Cerbomed Nemos®. La nostra esperienza consolidata e lo spirito pionieristico ci hanno consacrati come leader del settore, impegnati a fornire soluzioni innovative ed efficaci per i nostri pazienti. tVNS® per la Ricerca: Una panoramica Benvenuti all’avanguardia della ricerca sulla stimolazione del nervo vago. Il nostro dispositivo tVNS® R è progettato per flessibilità e precisione, offrendo la completa programmabilità wireless per studi clinici approfonditi. Con le app tVNS® Research e tVNS® Patient, la regolazione dei parametri di stimolazione, la raccolta dei dati e il feedback dei pazienti sono perfettamente integrati, migliorando la portata e l'accuratezza della tua ricerca. Siamo impegnati a facilitare i vostri studi clinici e forniamo supporto, inclusi rapporti di sicurezza CB completi per approvazioni etiche e accesso a una rete globale di esperti. Esplorate il potenziale del tVNS® R per tracciare nuove strade nella ricerca neurologica e nella cura del paziente. Programmazione completa e wireless dei parametri e tVNS® Triggered Con l’app tVNS® Research potete regolare wireless una gamma completa di parametri, inclusi frequenza, larghezza dell’impulso, intensità della corrente e intervalli di stimolazione. Offriamo inoltre un software tVNS® manager per PC, che consente la reazione a segnali trigger esterni (es. trigger ECG R-wave generato da sistema ECG esterno e trasferito al PC). Così, stimolazioni in closed-loop o triggered tVNS® possono essere realizzate in un setup scientifico. Precisione nella ricerca con il tVNS® Triggerbox Il nuovo tVNS® Triggerbox, uscito il 1° dicembre 2024, rappresenta un importante progresso nella ricerca tVNS®. Sviluppato in risposta ai feedback della comunità scientifica, il dispositivo risponde all’esigenza cruciale di protocolli di stimolazione più stabili e riproducibili. Sostituendo le connessioni Bluetooth con un sistema cablato, il Triggerbox riduce sensibilmente latenze e fluttuazioni, permettendo una sincronizzazione precisa con segnali trigger esterni. Questa innovazione migliora l’affidabilità degli esperimenti e semplifica l’integrazione con i framework di ricerca esistenti, promettendo di spingere oltre i confini della ricerca tVNS®. Ricerca e app Paziente Il vostro dispositivo tVNS® R vi dà accesso a due app: tVNS® Research e tVNS® Patient. Tutti i parametri tecnici possono essere facilmente riprogrammati e trasmessi wireless tramite l’app tVNS® Research, permettendo ai ricercatori di testare nuovi protocolli di stimolazione. Inoltre, potete raccogliere e memorizzare dati tecnici e paziente. L’app tVNS® Patient memorizza automaticamente tutti i dati tecnici (parametri di stimolazione, orari e durata, ecc.) e offre un questionario per il feedback del paziente. tVNS® Patient è pienamente conforme al GDPR, garantendo che i dati dei pazienti siano gestiti con la massima cura e riservatezza. Personalizzazione e Supporto per Studi Offriamo un adattamento individuale di tutti i componenti del dispositivo per specifici studi, ad esempio modificando il questionario per un miglior feedback o implementando parametri di stimolazione speciali o idee tecniche. Il dispositivo tVNS® R è definito come dispositivo per uso sperimentale. Possiamo fornire un rapporto CB che attesta la sicurezza secondo tutti gli standard per dispositivi medici, a supporto delle approvazioni etiche. Finora è stato accettato da tutti i comitati etici. Inoltre, offriamo una rete internazionale di esperti e possiamo indirizzare qualsiasi domanda a professionisti esperti nel mondo. Elettrodi Legacy e Hook Offriamo due diversi design di elettrodi con i nostri dispositivi tVNS®: L’elettrodo Hook (sinistra) consente una migliore fissazione e usabilità durante attività attive. Permette inoltre ai pazienti di indossare cuffie. L’elettrodo Legacy (destra) può essere usato per pazienti con orecchie piccole o forma speciale. Lo slider integrato permette una migliore adattabilità all’orecchio. Opzioni per Stimolazione Sham e Elettrodi fMRI La nota opzione di stimolazione sham sul lobo auricolare è possibile con l’elettrodo Legacy. Su richiesta forniamo anche opzioni sham più sofisticate e elettrodi compatibili con risonanza magnetica funzionale (fMRI). Supporto per Studi Offriamo un adattamento individuale di tutti i componenti del dispositivo per specifici studi, ad esempio modificando il questionario per un miglior feedback o implementando parametri di stimolazione speciali o idee tecniche. Il dispositivo tVNS® R è definito come dispositivo per uso sperimentale. Possiamo fornire un rapporto CB che attesta la sicurezza secondo tutti gli standard per dispositivi medici, a supporto delle approvazioni etiche. Finora è stato accettato da tutti i comitati etici. Inoltre, offriamo una rete internazionale di esperti e possiamo indirizzare qualsiasi domanda a professionisti esperti nel mondo. Prenota una consulenza personale con i nostri esperti di ricerca Contattate il nostro team di ricerca tVNS® per scoprire di più su tVNS® e ricevere informazioni personalizzate e supporto, come rapporti CB e istruzioni per l’uso (IFU). Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

Available Services Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Contact Like what you see? Get in touch to learn more. First Name Last Name Email Message Send Thanks for submitting!

Contains information about tVNS clinical research devices tVNS® R for Research Discover a Revolutionary Journey with Innovative tVNS® Research Device Meet the cutting-edge realm of vagus nerve stimulation research, where innovation meets precision in our state-of-the-art tVNS® R device. Crafted for flexibility and accuracy, it boasts complete wireless programmability, making it the perfect companion for in-depth clinical studies. Experience seamless control with the tVNS® Research and tVNS® Patient apps, integrating stimulation parameter adjustments, data collection, and patient feedback to elevate the depth and precision of your research. Our commitment extends beyond technology; we're here to streamline your clinical trials, providing robust support for your studies, including a thorough CB safety report for swift ethics approvals and access to a global network of experts. Uncover the limitless potential of tVNS® R as it pioneers revolutionary paths in neurological research and transforms the landscape of patient care. Your journey to groundbreaking discoveries starts here. tVNS® R for Research Transcutaneous Vagus Nerve Stimulation Device for Research Full Wireless Parameter Programmability Patient App for Data Collection Support for Clinical Trials Triggered tVNS® Legacy and Hook Electrode Sham Stimulation Research and Patient App Your tVNS® R device gives you access to two apps: the tVNS® Research and tVNS® Patient app. All technical parameters can easily be reprogrammed and wirelessly transmitted with the tVNS® Research app, allowing the researcher to try completely new stimulation protocols. In addition, you can collect and store technical and patient data. The tVNS® Patient app automatically stores all technical data (stimulation parameters, time and duration of the stimulation etc.) and offers a questionnaire for patient feedback. Support for Clinical Trials We offer an individual adaptation of all parts for certain studies, e.g by changing the questionnaire in order to allow better feedback from the patient, or through the implementation of special stimulation parameters or technical ideas. The tVNS® R device is defined as a device for investigational use. We can provide a CB report that proves the safety according to all medical device standards, in order to assist you with ethics approvals. So far, it has been accepted by all ethics committees. In addition, we offer an international expert network and can direct any questions to experienced people around the world. Triggered tVNS® We offer a separate PC-based tVNS® manager software. This software enables reaction to outside trigger signals (e.g. ECG R-wave trigger generated by an external ECG system, transferred to a PC). Thus, closed loop tVNS® or triggered tVNS® can be realized in a scientific setup. Legacy and Hook Electrode We offer two different types of electrode designs with our tVNS® devices: The Hook Electrode (left) comes standard with all new tVNS® devices. It offers bet ter fixation and usability during daily activities. The Legacy Electrode (right) can be used if the patient has small ears or a special ear shape. The integrated slider allows for better adaption to the ear. Sham Stimulation The well known sham stimulation at the ear lobe is still possible. Upon request, we support studies by providing other more sophisticated sham stimulation options.

tVNS, non-surgical treatment option for epilepsy. The most up-to-date health information about epilepsy causes, symptoms, treatment options Less seizures - more from life. Treat drug-resistant epilepsy wit h tVNS® Epilepsy An epileptic seizure is a clinical condition that occurs when the normal activity of the brain is disrupted by the temporary abnormal electrical acti vity in the nerve cells. Epilepsy is the recurrence of epileptic seizures and is considered a chronic disease. While anticonvulsants are commonly prescribed, many epileptic patients are resist ant to drug therapy. Treatment Options for Drug Resistant Epilepsy Epilepsy Surgery There are two methods of neurosurgery: removal of the brain region that causes seizures and surgical cutting of the neural pathways that cause seizures to spread. However, since these methods are only suitable for focal epilepsies, only a small proportion of epilepsy patients are suitable for this invasive procedure. In deep brain stimulation, electrodes are implanted in the brain. These electrodes are attached to a battery operated stimulator that is usually placed under the patient’s collarbone. Epileptic activity can be specifically affected at the baseline through current stimuli. Deep Brain Stimulation Invasive Vagus Nerve Stimulation In some patients, a treatment called “vagus nerve stimulation”, also known as brain pacemaker surgery, can be applied. With a surgical intervention, a battery is placed under the chest and an electrode wire is placed in the vagus nerve in the neck. With the help of the electrode, the vagus nerve is stimulated at regular intervals, which may reduce seizures. Transcutaneous Vagus Nerve Stimulation The tVNS® auricular vagus nerve stimulation device is a treatment option that provides vagus nerve stimulation through the ear with a smartphone-sized device and a special headset without any surgical intervention. From there, as with invasive vagus nerve stimulation, higher centers of the brain are activated, triggering an anticonvulsant effect. How does tVNS® treat epilepsy? In transcutaneous vagus nerve stimulation, mild electrical impulses are given to the cymba concha region in the outer auricle through a special ear electrode. These stimuli activate the vagus nerve, which passes directly under the skin in this region (auricular branch of the vagus nerve). The nerve first transmits these impuleses to the Nucleus Tractus Solitarius in the brain stem and are transmitted to many different regions of the diencephalon (midbrain) and cerebrum. These stimuli are also transmitted to the Norepinephrine (Noradrenaline) center, the Locus Coeruleus, and Serotonin center, the Dorsal Raphe nucleus. These transmitters affect one’s clarity, energy, and confidence. These 2 centers send these neurotransmitters to the entire brain, specifically to the parts that control thinking and feeling. more serotonin and norepinephrine are then sent to the Prefrontal Cortex and are inhibited in the Hippocampus and Anterior Thalamus regions, which reduces anxiety and panic. This mechanism causes the frequency or severity of seizures to be reduced or stopped entirely. tVNS has helped hundreds of patients suffering from epilepsy to reduce or completely eliminate their seizures and lead a more self-determined life, without the need for surgery. “It’s wonderful that with tVNS® I have found a therapy option that makes me feel better without needing surgery.” Katja S. from Munich

tVNS non-surgical, drug-free treatment with low side effects. The most up-to-date health information on the causes, symptoms, and treatment options of depression. Gain more freedom and self-determination. Treat depression with tVNS®. Depression Depression is a mood disorder that negatively affects the way one thinks and feels, interfering with one’s daily activities. It is characterized by a p ersistent feeling of sadness and hopelessness along with a loss of interest in activities that were once enjoyed. Treatment Options for Depression Medication There are different types of medications that can be used to treat depression including serotonin-norepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), Monoamine Oxidase Inhibitors (MAOIs), tricyclic and tetracyclic antidepressants, and many others. The doctor or pharmacist will inform patients about the possible mild or severe side effects of these drugs upon prescription, which will be followed by close monitoring for the first few weeks after starting the medication. Psychotherapy Psychotherapy is a general term for continuing treatment of depression which entails talking to a mental health professional about one’s condition and related issues. Psychotherapy is also known as talk therapy or psychological therapy. Different types of psychotherapy, such as cognitive behavioral therapy or trauma therapy, can be effective for depression depending on the patient. Hospital Treatment Some cases of severe depression requir e in-patient hospital stays. This may be necessary when the individual is unable to properly care for themselves and is in danger of harming themselves or others. Psychiatric treatment in a hospital can help an individual stay calm and safe until their mood improves. Partial hospital or day treatment programs may also help some individuals. Electroconvulsive therapy (ECT) In EC T, electrical currents are passed through the brain to impact the function and effect of neurotransmitters in your brain to relieve depression. ECT is usually used for people who don’t get better with medications, can’t take antidepressants for health reasons, or are at high risk of suicide. Transcranial magnetic stimulation (TMS) TMS may be an option for those who haven’t responded to antidepressants. During TMS, a treatment coil, placed against your scalp, sends brief magnetic pulses to stimulate nerve cells in your brain that are involved in mood regulation and depression. Transcutaneous Vagus Nerve Stimulation (tVNS) The tVNS® auricular vagus stimulation device is a treatment option that provides vagus nerve stimulation through the ear. The increase in parasympathetic activity from the stimulation provides relaxation and a calming effect. The increased release of serotonin provides a positive change in mood and the increased sleep quality leads to an improvement in the overall quality of life. Significant decreases in Hamilton Rating Scale for Depression, increase in Resting State Functional Connectivity and decrease in Beck Depression Inventory can be observed. tVNS® has very low side effects compared to drug options. tVNS® has helped many patients suffering from depression to reduce or completely eliminate their symptoms and lead a more self-determined and free life. Contact Us

During the last 20 years, basic and clinical research has unraveled many of these questions and augmented our understanding of tVNS pathways and physiologic effects. The number of publications increased exponentially within the last three years and continues to grow rapidly. Many questions have been addressed and therapeutic indications beyond the treatment of drug-resistant epilepsy and depression are steadily expanding and continue to be explored. Clinical Studies Vagus nerve stimulation (VNS) has become a therapeutic option for patients with resistant epilepsy and depression. The field of tVNS is quickly progressing due to its non-invasive nature, presenting a promising alternative to the side effects associated with invasive VNS. Notably, tVNS stands out for its accessibility, affordability, and easiness of application compared to traditional VNS methods. However, the non-invasive stimulation of the outer ear brings forth new queries regarding optimal stimulation sites, stimulus parameters, and the physiological pathways of transcutaneous auricular VNS. Over the past two decades, both basic and clinical research have made significant strides, unraveling these complexities, enhancing our comprehension of tVNS pathways and physiological effects. The exponential growth in publications over the last years underscores the expanding knowledge base. As we delve deeper, therapeutic applications and achievable objectives of tVNS beyond epilepsy and depression treatment are continually broadening, promising new horizons in the field. Redgrave 2018: Safety and Tolerability of tVNS Wrede Case Study 2019 : Sustained seizure freedom with transcutaneous vagal nerve stimulation in drug-resistant epilepsy caused by subcortical band heterotopias Yakunina 2016: Optimization of Transcutaneous Vagus Nerve Stimulation Using Functional MRI Ellrich 2019: Transcutaneous Auricular Vagus Nerve Stimulation Study Bauer 2015: Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial Straube 2015: Treatment of chronic migraine with Transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial tVNS JOURNAL The "tVNS Special Issue", which includes 17 studies on our tVNS devices, has been published in the "Journal Autonomic Neuroscience" by Elsevier, the official journal of the International Society for Autonomic Neuroscience. Journal For more please contact us info@tvns.health